RENAL INJURY INHIBITING DEVICES, SYSTEMS, AND METHODS EMPLOYING LOW-FREQUENCY ULTRASOUND OR OTHER CYCLICAL PRESSURE ENERGIES
    91.
    发明申请
    RENAL INJURY INHIBITING DEVICES, SYSTEMS, AND METHODS EMPLOYING LOW-FREQUENCY ULTRASOUND OR OTHER CYCLICAL PRESSURE ENERGIES 审中-公开
    使用低频超声或其他循环压力的肾损伤抑制装置,系统和方法

    公开(公告)号:US20160332003A1

    公开(公告)日:2016-11-17

    申请号:US15218327

    申请日:2016-07-25

    摘要: Improved devices, systems, and methods treatment of patients can be used to help mitigate injury to the kidneys by applying cyclical mechanical pressure energy at low intensities. The energy often be selectively directed from non-invasive transducers disposed outside the patients. The energy will typically comprise low frequency ultrasound energy, shock wave energy, or the like, and may induce the generation and/or release of nitric oxide, thereby enhancing perfusion and ameliorating tissue damage. Superimposed micro and macro duty cycles may help avoid thermal and other injury to tissues of the patient during treatment. Bilateral treatments are facilitated by a support structure that orients at least one transducer toward each kidney.

    摘要翻译: 改进的设备,系统和方法治疗患者可用于通过在低强度下施加周期性机械压力能量来帮助减轻对肾脏的损伤。 能量通常从布置在患者外部的非侵入性换能器选择性导向。 能量通常包括低频超声能量,冲击波能量等,并且可以诱导一氧化氮的产生和/或释放,从而增强灌注并改善组织损伤。 叠加的微观和微观占空比可能有助于避免治疗期间患者组织的热和其他损伤。 通过支撑结构来促进双侧治疗,所述支撑结构为每个肾定向至少一个换能器。

    NONINVASIVE ASSESSMENT OF CARDIAC RESYNCHRONIZATION THERAPY
    92.
    发明申请
    NONINVASIVE ASSESSMENT OF CARDIAC RESYNCHRONIZATION THERAPY 审中-公开
    心脏再生治疗无效评估

    公开(公告)号:US20160317840A1

    公开(公告)日:2016-11-03

    申请号:US15009817

    申请日:2016-01-28

    申请人: Medtronic, Inc.

    IPC分类号: A61N7/00 A61N1/362 A61B5/0408

    摘要: Systems, methods, and interfaces are described herein for noninvasively determining whether a patient can benefit from cardiac resynchronization therapy. One exemplary method involves delivering ultrasonic energy to cardiac tissue. In response to delivering ultrasonic energy to the cardiac tissue, receiving, with a processing unit, a torso-surface potential signal from each of a plurality of electrodes distributed on a torso of a patient. For at least a subset of the plurality of electrodes, calculating, with the processing unit, a torso-surface activation time based on the signal sensed from the electrode. Presenting, by the processing unit, to a user, an indication of a degree of dyssynchrony of the torso-surface activation times via a display.

    摘要翻译: 本文描述了系统,方法和界面,用于非侵入性地确定患者是否可以从心脏再同步治疗中受益。 一种示例性方法涉及将超声能量递送到心脏组织。 响应于向心脏组织递送超声能量,用处理单元接收分布在患者躯干上的多个电极中的每一个的躯干表面电位信号。 对于多个电极的至少一个子集,基于从电极感测的信号,利用处理单元计算躯干表面激活时间。 由处理单元向用户呈现经由显示器的躯干表面激活时间的不同步程度的指示。

    ARRANGEMENT AND METHOD FOR THE IN-VITRO and IN-VIVO TREATMENT OF BRONCHIAL TUMORS
    95.
    发明申请
    ARRANGEMENT AND METHOD FOR THE IN-VITRO and IN-VIVO TREATMENT OF BRONCHIAL TUMORS 审中-公开
    弓形肿瘤体内和体内治疗的装置和方法

    公开(公告)号:US20160144147A1

    公开(公告)日:2016-05-26

    申请号:US14904906

    申请日:2014-07-09

    IPC分类号: A61M16/14 A61N7/02 A01N1/02

    摘要: The invention relates to an arrangement and method for the in-vitro and in-vivo treatment of bronchial tumors.The aim of the invention to provide an arrangement and a method for operating said arrangement for the in-vitro and in-vivo treatment of bronchial tumors, with said arrangement making the lungs receptive to ultrasound in order to allow the mechanical ultrasound waves to be guided through the healthy lung tissue to the tumor tissue in an optimized manner for the use of FUS therapy, is achieved in that the arrangement comprises a ventilation and respirator system (1) for a lung part to be provided with a gas for respiratory purposes (33), a device for the controlled ventilation and flooding (2) of a lung part to be flooded (34) with a liquid, a therapy system (4), and a central control unit (5), wherein the therapy system (4) consists of at least one therapeutic ultrasonic transducer (40), an imaging-monitoring system (42), and a temperature-monitoring system (41), and the central control unit (5) is connected to the therapeutic ultrasonic transducer (40), the respirator system (1), the device for the controlled ventilation and flooding processes (2), the imaging-monitoring system (42), and the temperature-monitoring system (41) for data-transmission purposes, the respirator system (1) and the device for the controlled ventilation and flooding (2) processes have a gas- and liquid-conducting connection to a lung tube (3), the lung tube (3) can be inserted into a lung containing a tumor (35) in an intratracheal manner, and therapeutic ultrasound doses can be administered by the ultrasonic transducer (40).

    摘要翻译: 本发明涉及支气管肿瘤的体外和体内治疗的布置和方法。 本发明的目的是提供一种用于操作用于支气管肿瘤的体外和体内治疗的所述装置的装置和方法,其中所述布置使肺接受超声以允许机械超声波被引导 通过健康的肺组织以优化的方式使用FUS治疗,实现了该装置包括通气和呼吸器系统(1),用于肺部被提供用于呼吸目的的气体(33 ),用于用液体淹没(34)的肺部分受控通气和淹没(2)的装置,治疗系统(4)和中央控制单元(5),其中所述治疗系统(4) 由至少一个治疗性超声波换能器(40),成像监视系统(42)和温度监视系统(41)组成,并且中央控制单元(5)连接到治疗性超声波换能器(40) 呼吸器系统(1), 用于受控通风和淹水过程的设备(2),成像监测系统(42)和用于数据传输目的的温度监测系统(41),呼吸器系统(1)和用于受控通风和 淹没(2)过程具有与肺管(3)的气液导液连接,肺管(3)可以以气管内方式插入含有肿瘤(35)的肺中,并且治疗性超声剂量可以 由超声波换能器(40)施用。

    Ultrasonic treatment probe
    97.
    发明授权
    Ultrasonic treatment probe 有权
    超声波治疗探头

    公开(公告)号:US09186526B2

    公开(公告)日:2015-11-17

    申请号:US14132316

    申请日:2013-12-18

    发明人: Tsunetaka Akagane

    IPC分类号: A61N7/00 A61B17/32

    摘要: An ultrasonic probe includes a first coupled vibration member and a second coupled vibration member each of which extends along a longitudinal axis between a first anti-node position of an ultrasonic vibration and a second anti-node position of the ultrasonic vibration located to a distal direction side of the first anti-node position. The second coupled vibration member vibrates in the same mode as the first coupled vibration member. A first groove of the first coupled vibration member and a second groove of the second coupled vibration member cooperate with each other and thereby form at least a part of a passage inside a multiple-members vibrating portion formed by the first coupled vibration member and the second coupled vibration member.

    摘要翻译: 超声波探头包括第一耦合振动部件和第二耦合振动部件,每个振动部件沿着纵向轴线延伸超声波振动的第一反节点位置和位于远端方向的超声波振动的第二反节点位置之间 侧的第一个反节点位置。 第二耦合振动构件以与第一耦合振动构件相同的模式振动。 第一联接振动部件的第一槽和第二联接振动部件的第二槽彼此配合,从而形成由第一联接振动部件形成的多部件振动部分内的通路的至少一部分, 耦合振动件。

    CORNEAL VITRIFICATION, METHODS AND DEVICES TO PRODUCE CORNEAL VITRIFICATION AND METHODS OF USE THEREOF
    99.
    发明申请
    CORNEAL VITRIFICATION, METHODS AND DEVICES TO PRODUCE CORNEAL VITRIFICATION AND METHODS OF USE THEREOF 有权
    角膜修复,生产角膜修复的方法和装置及其使用方法

    公开(公告)号:US20150230985A1

    公开(公告)日:2015-08-20

    申请号:US14674992

    申请日:2015-03-31

    IPC分类号: A61F9/008 A61F9/007

    摘要: The invention includes: a new composition of matter (a composite comprising a naturally occurring in vivo cornea in an in situ eye together with at least one volume of vitrified non-naturally occurring corneal stromal tissue formed within the naturally occurring corneal stromal tissue) wherein the vitrified tissue is modified in structure and properties from its naturally occurring condition into a non-naturally occurring glass-like condition with modifications including but not limited to increased elastic modulus; methods for producing and using the new composition of matter for modifying corneal structure and properties, including but not limited to corneal optical aberrations; wound closure adhesion and transplant adhesion; and a photo vitrification system for producing the new composition of matter comprising at least one photon source with controllable treatment parameters. A reverse template can be added to corneal vitrification systems to increase vitrification and modifications of structure and properties.

    摘要翻译: 本发明包括:一种新的物质组合物(包括在原位眼中的天然存在的体内角膜以及在天然存在的角膜基质组织内形成的至少一个玻璃化非天然存在的角膜基质组织体积的复合物),其中 玻璃化组织的结构和性质从其天然存在的状态改变成非天然存在的玻璃状状态,其中包括但不限于增加的弹性模量; 用于生产和使用用于修饰角膜结构和性质的新组合物的方法,包括但不限于角膜光学像差; 伤口闭合粘连和移植附着力; 以及用于产生包含至少一个具有可控处理参数的光子源的新组合物的照相玻璃化系统。 可以向角膜玻璃化系统添加反向模板,以增加玻璃化和结构和性质的修改。

    CORNEAL VITRIFICATION, METHODS AND DEVICES TO PRODUCE CORNEAL VITRIFICATION AND METHODS OF USE THEREOF
    100.
    发明申请
    CORNEAL VITRIFICATION, METHODS AND DEVICES TO PRODUCE CORNEAL VITRIFICATION AND METHODS OF USE THEREOF 有权
    角膜修复,生产角膜修复的方法和装置及其使用方法

    公开(公告)号:US20150230979A1

    公开(公告)日:2015-08-20

    申请号:US14674890

    申请日:2015-03-31

    IPC分类号: A61F9/008 A61N7/00 A61F9/007

    摘要: The invention includes: a new composition of matter (a composite comprising a naturally occurring in vivo cornea in an in situ eye together with at least one volume of vitrified non-naturally occurring corneal stromal tissue formed within the naturally occurring corneal stromal tissue) wherein the vitrified tissue is modified in structure and properties from its naturally occurring condition into a non-naturally occurring glass-like condition with modifications including but not limited to increased elastic modulus; methods for producing and using the new composition of matter for modifying corneal structure and properties, including but not limited to corneal optical aberrations; wound closure adhesion and transplant adhesion; and a photovitrification system for producing the new composition of matter comprising at least one photon source with controllable treatment parameters. A reverse template can be added to corneal vitrification systems to increase vitrification and modifications of structure and properties.

    摘要翻译: 本发明包括:一种新的物质组合物(包括在原位眼中的天然存在的体内角膜以及在天然存在的角膜基质组织内形成的至少一个玻璃化非天然存在的角膜基质组织体积的复合物),其中 玻璃化组织的结构和性质从其天然存在的状态改变成非天然存在的玻璃状状态,其中包括但不限于增加的弹性模量; 用于生产和使用用于修饰角膜结构和性质的新组合物的方法,包括但不限于角膜光学像差; 伤口闭合粘连和移植附着力; 以及用于产生包含至少一个具有可控处理参数的光子源的新组合物的光生产系统。 可以向角膜玻璃化系统添加反向模板,以增加玻璃化和结构和性质的修改。